Intersect ENT is an ear, nose, and throat medical technology company. It offers steroid releasing implants that are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. These products include the PROPEL family of products and the SINUVA sinus implant. The PROPEL family of products are used in adult patients to reduce inflammation and maintain patency following sinus surgery, primarily in hospitals and ambulatory surgery centers, with applications in the physician office setting of care in conjunction with balloon dilation and following post-surgical debridement. SINUVA is a physician-administered drug, designed to be used in the physician office setting of care to treat adult patients who have had ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps.